Lantern Pharma Inc (LTRN) — Strategic Asset Allocation Index
Lantern Pharma Inc (LTRN) has a Strategic Asset Allocation Index of 0.1% as of June 2023. Strategic assets (PP&E of $49.95K plus long-term investments of $-) total $49.95K, measured against net assets of $48.26 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Lantern Pharma Inc Strategic Asset Allocation Index (2019–2022)
This chart shows how Lantern Pharma Inc's Strategic Asset Allocation Index has evolved across 4 annual periods from 2019 to 2022. As of June 2023, the index stands at 0.1%, representing strategic assets of $49.95K against net assets of $48.26 Million USD. Explore LTRN operating cash flow to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Lantern Pharma Inc (2019–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Lantern Pharma Inc from 2019 to 2022, covering 4 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Lantern Pharma Inc (LTRN) market capitalisation.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 0.1% | $48.01K | $48.01K | $- | $56.04 Million | ▼ -0.2 pp |
| 2021 | 0.3% | $216.19K | $216.19K | $- | $71.57 Million | ▲ +0.2 pp |
| 2020 | 0.1% | $21.51K | $21.51K | $- | $19.70 Million | ▼ -0.8 pp |
| 2019 | 0.9% | $8.76K | $8.76K | $- | $943.28K | — |